Clinical Trials Logo

Clinical Trial Summary

PTSD is a debilitating mental disorder that may develop after experiencing or witnessing a life-threatening event. With appropriate care, treatment efficiency is variable and around 20% of the patients do not respond to psychological treatment. Complementary treatments are needed. as PTSD implied autonomic nervous system (ANS) dysfonction, complementary treatment focusing on ANS regulation, as welle as musicotherapy, may have an interest.


Clinical Trial Description

The aim is to evaluate the impact of musicotherapy on PTSD symptoms, and severity using a RCT Symptoms will be evaluated using questionaires (PCL and quality of life) severity will be measured using neurological soft signs assessment, connectomic functions and ANS regulation ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03990064
Study type Interventional
Source Institut de Recherche Biomedicale des Armees
Contact
Status Terminated
Phase N/A
Start date February 1, 2020
Completion date July 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT00356278 - D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD Phase 2/Phase 3
Completed NCT00635635 - Guided Imagery for Military Sexual Trauma-Related Posttraumatic Stress Disorder (PTSD) N/A
Completed NCT02560389 - Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753) Phase 4